Adriana Olar to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications Adriana Olar has written about Xenograft Model Antitumor Assays.
Connection Strength
0.187
-
Current clinical management of patients with glioblastoma. Cancer Rep (Hoboken). 2019 12; 2(6):e1216.
Score: 0.160
-
Mesenchymal differentiation mediated by NF-?B promotes radiation resistance in glioblastoma. Cancer Cell. 2013 Sep 09; 24(3):331-46.
Score: 0.026